Schrödinger (SDGR) and Revvity (RVTY) on Friday announced collaborations with Eli Lilly (LLY) to integrate their respective ...

An international research team reveals new molecular mechanisms associated with pathogenic mutations in the protein transthyretin that cause ...

"As a leader in computational drug discovery, Schrödinger is pleased to partner with Lilly TuneLab," stated Pat Lorton, chief technology officer and chief operating officer, software at Schrödinger.

A recent study shows that computer algorithms can be used to find molecules that can be developed into anti-inflammatory drugs. In the article, the researchers also describe how the same strategy can ...

A team of chemists has unveiled a novel method to simplify the synthesis of piperidines, a key structural component in many pharmaceuticals. The study combines biocatalytic carbon-hydrogen oxidation ...

Researchers from the University of Cincinnati College of Medicine and Cincinnati Children's Hospital have found a new method to increase both speed and success rates in drug discovery. The study, ...

Disease modeling and target identification are critical and time-consuming portions of the drug discovery process and areas where artificial intelligence (AI) is already making a substantial impact. A ...

Vijayapura: The Centre of Advanced Medical Research (CAMR), in collaboration with the school of applied science and ...

Schrödinger (SDGR) stock is in focus as the firm teams up with Eli Lilly (LLY) to integrate its LiveDesign software with ...